De Novo AI in the Acute Care Pathway: How Queen of Hearts Redefines Emergency Triage Economics and Cath Lab Utilization
Dr. Dereck Mush, MD, MBA
Aidoc
AI triage software assisting radiologists with critical, time-sensitive imaging findings.
What they do
The company develops artificial intelligence software that integrates directly into radiologists' workflows. It automatically flags urgent abnormalities, such as brain hemorrhages or pulmonary embolisms, on CT scans, allowing clinicians to prioritize critical cases immediately. Its FDA-cleared CARE Body CT Multi-Triage, cleared in January 2026, was approved for a Medicare New Technology Add-on Payment under the CMS FY 2027 inpatient rule, effective October 1, 2026.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Tel Aviv, Israel
- Region
- Middle East & Africa
- Founded
- 2016
- Total funding
- $250M raised
Notable investors: General Catalyst, Square Peg Capital, TCV, Magma Venture Partners.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
From IT Expense to Revenue Driver: How CMS NTAP Activates the Clinical AI Commercial Flywheel
Dr. Dereck Mush, MD, MBA
Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Decentralizing the Neuro-ICU: The Clinical Economics of Quantitative Bedside Brain Monitoring
Dr. Dereck Mush, MD, MBA